Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) Return on Sales (2016 - 2025)

Historic Return on Sales for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to 0.27%.

  • Utah Medical Products' Return on Sales fell 900.0% to 0.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3%, marking a year-over-year decrease of 500.0%. This contributed to the annual value of 0.33% for FY2024, which is 100.0% up from last year.
  • Per Utah Medical Products' latest filing, its Return on Sales stood at 0.27% for Q3 2025, which was down 900.0% from 0.31% recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' Return on Sales ranged from a high of 0.36% in Q3 2024 and a low of 0.27% during Q3 2025
  • In the last 5 years, Utah Medical Products' Return on Sales had a median value of 0.32% in 2024 and averaged 0.32%.
  • As far as peak fluctuations go, Utah Medical Products' Return on Sales surged by 1200bps in 2021, and later tumbled by -900bps in 2025.
  • Quarter analysis of 5 years shows Utah Medical Products' Return on Sales stood at 0.32% in 2021, then decreased by -5bps to 0.3% in 2022, then grew by 15bps to 0.35% in 2023, then dropped by -9bps to 0.32% in 2024, then fell by -15bps to 0.27% in 2025.
  • Its last three reported values are 0.27% in Q3 2025, 0.31% for Q2 2025, and 0.31% during Q1 2025.